30283B1
Transfusion Vein to Nonautologous with 4-Factor Prothrombin Complex Concentrate, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | 0 Circulatory |
| Operation | 2 Transfusion |
| Body Part | 8 Vein |
| Approach | 3 Percutaneous |
| Device | B 4-Factor Prothrombin Complex Concentrate |
| Qualifier | 1 Nonautologous |
Operation Definition
Putting in blood or blood products
Procedure Overview
Transfusion is the administration of blood or a blood-derived product directly into a patient's circulation, most commonly packed red blood cells, platelets, fresh frozen plasma, or cryoprecipitate. It is used to treat significant blood loss, severe anemia, clotting disorders, or shortages of specific blood components caused by disease or treatment such as chemotherapy.
For a patient, a transfusion means receiving donated or, less commonly, their own previously collected blood through an intravenous line. The goal is to quickly restore oxygen-carrying capacity, clotting ability, or blood volume when the body cannot do so on its own. Transfusions are generally short procedures performed at the bedside, though the underlying condition prompting them can range from routine surgical blood loss to a life-threatening hemorrhage.
Anatomy & Axis Detail
Vein
This code applies when the specific vein used for transfusion is not further specified as peripheral or central, capturing instances where documentation identifies venous access generically rather than by exact anatomic location. Veins serve as the standard conduit for transfusing red cells, platelets, plasma, and other blood products because their lower pressure and thinner walls allow safer, more controlled infusion than arterial access. The unspecified designation is used when the operative or nursing record notes only that a product was given intravenously without detailing whether the line was peripheral or centrally placed, which can occur in emergency documentation or transcription from external records. Coders should seek clarification when possible, since specifying peripheral versus central vein provides more precise clinical detail, but this general vein code remains appropriate when the record genuinely does not distinguish the two.
Approach: Percutaneous
In Administration, Percutaneous denotes a substance delivered by needle injection through the skin, such as an intramuscular or subcutaneous injection, without cutting or scope guidance. It differs from External, where the substance is applied to the skin surface itself, and from Via Natural or Artificial Opening, where it is introduced through an orifice rather than through a puncture.
Substance: 4-Factor Prothrombin Complex Concentrate
4-Factor Prothrombin Complex Concentrate identifies infusion of a concentrate containing factors II, VII, IX, and X, used for urgent reversal of vitamin K antagonist anticoagulation or management of certain acquired coagulopathies. Unlike Antihemophilic Factors or Factor IX, which replace a single clotting protein, this product corrects multiple factor deficiencies simultaneously, making it suited to broad, rapid hemostatic correction.
Qualifier: Nonautologous
This Administration qualifier marks a transfused substance, usually blood or a blood product, as coming from a donor other than the patient. It is the general counterpart to Autologous, and is further broken down elsewhere by donor relationship into related and unrelated allogeneic sources for certain transfusion products such as bone marrow or stem cells.
Coding & Documentation
Assigning a code from this family depends on documentation specifying the exact blood product given, whether it was autologous or from a donor, and the vessel or route used for infusion, such as a peripheral vein or central venous catheter. Nursing and physician notes recording units transfused, product type, and any reaction are the primary support for the code. A recurring error is selecting the wrong substance qualifier, for example coding platelets when frozen plasma was actually given, or overlooking that autologous blood requires a different qualifier than banked donor blood. Coders should also confirm the route matches what is documented rather than defaulting to peripheral vein.